Venus Concept (NASDAQ:VERO) Shares Up 1.6% – Still a Buy?

Venus Concept Inc. (NASDAQ:VERO)’s stock price rose 1.6% during mid-day trading on Friday . The company traded as high as $0.42 and last traded at $0.39. Approximately 165,537 shares changed hands during trading, a decline of 64% from the average daily volume of 465,373 shares. The stock had previously closed at $0.38.

Venus Concept Stock Performance

The firm’s 50 day moving average is $0.35 and its two-hundred day moving average is $0.50. The company has a debt-to-equity ratio of 2.83, a quick ratio of 1.18 and a current ratio of 1.86. The stock has a market capitalization of $2.80 million, a PE ratio of -0.05 and a beta of 0.47.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC grew its position in Venus Concept Inc. (NASDAQ:VERO) by 100.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 666,702 shares of the company’s stock after acquiring an additional 333,366 shares during the period. Masters Capital Management LLC owned about 10.49% of Venus Concept worth $522,000 at the end of the most recent quarter. 87.41% of the stock is owned by institutional investors.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.